Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Regains Nasdaq Compliance but Faces One-Year Mandatory Panel Monitor

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$2.4
Mkt Cap
$1.569M
52W Low
$2.35
52W High
$3,417.009
52W Position info
2.1% above low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

PFSA is trading near its 52-week low of $2.35 (2.1% above the low) on light trading volume (0.1× avg).

Summary

Profusa confirmed Nasdaq compliance on September 9, 2026, but is now subject to a one-year Mandatory Panel Monitor that removes any grace period for future Equity Rule violations.


Key Events · Corporate Governance and Compliance · PFSA

  • Nasdaq Compliance Confirmed

    Nasdaq confirmed on September 9, 2026 that Profusa has demonstrated compliance with Bid Price Rule 5550(a)(2) and Equity Rule 5550(b)(1), resolving the immediate delisting threat.

  • One-Year Mandatory Panel Monitor

    Profusa is now subject to a one-year Mandatory Panel Monitor. Any future Equity Rule deficiency will result in an immediate Staff Delisting Determination with no compliance plan or cure period, though the company may appeal.

  • Financial Distress Context

    The monitor comes amid going-concern doubts, a Q2 2026 loss of $8.8M, and cash of only $0.7M as reported in the August 19, 2026 10-Q.

  • Stock Near 52-Week Low

    The stock trades at $2.40, near its 52-week low of $2.35, leaving little buffer above the Nasdaq minimum bid price requirement.


Analysis · PFSA · Industrial Applications And Services

Profusa received Nasdaq's confirmation that it has regained compliance with the Bid Price and Equity Rules, resolving the immediate delisting threat that drove its July reverse split. However, the company is now under a one-year Mandatory Panel Monitor: any future Equity Rule deficiency will trigger an immediate Staff Delisting Determination with no compliance plan or cure period. Given the company's going-concern doubts, $0.7M cash balance, and stock trading near its 52-week low, this monitor represents a significant ongoing listing risk.

How filings like this one have moved

In the 30 days to Sep 17, 2026, 35.7% of the 1179 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PFSA was trading at $2.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $2.35 to $3,417.01. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Sep 16, 2026, 6:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.85
Real-time Price: $1.82 info
Change: -$0.0304 (-2%) info
Market Cap: $1.078M info
PFSA
Sep 15, 2026, 6:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.82 info
Change: -$0.4804 (-21%) info
Market Cap: $1.078M info
PFSA
Sep 01, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.02
Real-time Price: $1.82 info
Change: -$1.20 (-40%) info
Market Cap: $1.078M info
PFSA
Aug 28, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $2.86
Real-time Price: $1.82 info
Change: -$1.04 (-36%) info
Market Cap: $1.078M info
PFSA
Aug 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.41
Real-time Price: $1.82 info
Change: -$3.59 (-66%) info
Market Cap: $1.078M info